Sun, Jul 14, 2024

top blank header

Nephro Flash Vol-8 No-3, 2022

Nephro Flash Vol-8 No-3, 2022

Introduction The 2019 coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 (SARSCoV- 2) has been declared a pandemic and has infected around 21.2 million people, causing over 761,000 deaths in countries and territories worldwide. COVID-19 presents as an acute infection of the upper and lower airways, leading to pneumonia and also affecting several other tissues and organs.
Potassium abnormalities in CKD Chronic kidney disease (CKD) is progressive loss of renal functions eventually requiring renal replacement therapy. It is a cause of major health concern, particularly because of the high morbidity and mortality rates it is associated with. It is defined as kidney damage or an estimated glomerular filtration rate (eGFR) < 60 ml/min per 1.73 m2, persisting for ≥ 3 months.1 The last few years have witnessed progressive increase in the burden of CKD, with its prevalence ranging from 13-16% in some of the developed countries and between 2-16% in the developing countries (Figure 1).